Tel Aviv-Israel Chemicals Ltd. said Sept. 11 that it has completed a US$240 million offering of its debentures to institutional investors and the public. The sale of debentures was authorized to diversify sources of funding. The proceeds will be used for its future needs, including potential mergers and acquisitions.
Transparency Across the Fertilizer Value-Chain